Get started
Author

Thomas J. Schnitzer

Observed names: Schnitzer, Thomas J, Schnitzer, Thomas J., T.J Schnitzer, T.J. Schnitzer
OpenAlex ID: A5012268632
Response relationship of VAS and Likert scales in osteoarthritis efficacy measurement
2003 · J.A Bolognese, T.J Schnitzer, et al. · Osteoarthritis and Cartilage · 144
PDF
The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis
1999 · Thomas J. Schnitzer, Ken Truitt, et al. · Clinical Therapeutics · 136
Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: A randomized, double-blind, placebo-controlled study
1999 · Thomas J. Schnitzer, Marc Kamin, et al. · Arthritis & Rheumatism · 96
CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial
2018 · Y. Jin, C. Smith, et al. · Osteoarthritis and Cartilage · 65
PDF
Subregional femorotibial cartilage morphology in women – comparison between healthy controls and participants with different grades of radiographic knee osteoarthritis
2009 · M.-P. Hellio Le Graverand, R.J. Buck, et al. · Osteoarthritis and Cartilage · 51
PDF
Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time
2018 · I.T. Haider, S.M. Lobos, et al. · Osteoporosis International · 48
Osteoarthritis treatment update
1993 · Thomas J. Schnitzer · Postgraduate Medicine · 33
OARSI Clinical Trials Recommendations: Key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis
2015 · E. Losina, J. Ranstam, et al. · Osteoarthritis and Cartilage · 32
Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2—selective inhibitors: analysis of a large United States claims database
2001 · Thomas J. Schnitzer, Sheldon X. Kong, et al. · Clinical Therapeutics · 24
Extended and Controlled Release Liposomal Formulated Dexamethasone (TLC599) for Chronic Knee Osteoarthritis Pain (EXCELLENCE): A Phase 3, Randomized, Placebo-controlled Clinical Trial
2025 · Zhaohua Zhu, Thomas J. Schnitzer, et al. · Osteoarthritis and Cartilage · 3
International Spinal Cord Injury Fracture History Extended Data Set
2025 · Leslie R. Morse, William A. Bauman, et al. · Topics in Spinal Cord Injury Rehabilitation · 1
Physical function status in hip and knee osteoarthritis: pain, psychological features and functional capacity play a major role
2023 · S. Espinosa-Salas, L. Bagherzadeh, et al. · Osteoarthritis and Cartilage · 1
PDF
Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity
2026 · Thomas J. Schnitzer, David J. Hunter, et al. · New England Journal of Medicine
PDF
Impact of Kellgren-lawrence Score on the Efficacy of Anti-ngf Analgesia in Knee OA Patients.
2026 · Rami Jabakhanji, Joana Barroso, et al. · Osteoarthritis and Cartilage
Weekly treatment with oral alendronate maintains bone mineral increases gained after one year of romosozumab treatment, in women with chronic spinal cord injury
2026 · Laura E. Crack, Reza Kakavand, et al. · Journal of Spinal Cord Medicine
Prediction of post-surgical disability in knee osteoarthritis patients
2023 · L. Bagherzadeh, S. Espinosa-Salas, et al. · Osteoarthritis and Cartilage
PDF
Rofecoxib vs Celecoxib vs Acetaminophen for Treatment of Osteoarthritis—Reply
2002 · Gregory P. Geba, Adam B. Polis, et al. · JAMA
Works count: 21
Citation count: 634
H-index: 9
I10-index: 9
Year
Topic
Type